Can Pemirolast Potassium Tablets be taken again after recurrence following discontinuation?

After discontinuation of olopatadine hydrochloride tablets, recurrence of symptoms should not be self-treated with continued use. It is essential to first consult a physician to determine the cause of recurrence and assess the current condition before deciding whether medication should be resumed and what treatment plan should be followed, so as to avoid risks associated with unsupervised use. Detailed explanations are as follows:

Olopatadine hydrochloride tablets are antihistamines primarily used to treat allergic conditions such as allergic rhinitis and allergic conjunctivitis. They work by blocking histamine receptors to relieve symptoms like sneezing and itching. Recurrence after stopping the medication may result from incomplete control of the underlying condition, re-exposure to allergens, or other triggering factors—meaning that simply resuming the previous treatment regimen may not always be appropriate.

Self-medicating again could lead to inadequate symptom control due to inappropriate dosing or failure to address the actual triggers of recurrence, and might even mask other underlying health issues. A physician will evaluate factors such as the time interval since last treatment, severity of symptoms, and prior response to medication to determine whether dosage adjustments, alternative medications, or additional measures—such as allergen avoidance—are necessary.

During treatment, it is important to strictly follow medical instructions, keep records of symptom changes and medication responses, and attend regular follow-up appointments to ensure therapy remains precisely tailored to the current condition, thereby improving symptom control.